Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin for Glabellar Lines
NCT03289169Phase 4Completed
- Sponsor
- Medytox Inc.
- Start
- Dec 2016
- Primary completion
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Meditoxin in glabellar lines, sponsored by Medytox Inc.. Started Dec 2016; status: completed.
02
Drugs
Meditoxin
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT03289169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289169.